# Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome

> **NCT01197040** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 117 (actual)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Prednisone
- **DRUG:** acid mycophenolic (Myfortic)

## Key facts

- **NCT ID:** NCT01197040
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2014-07
- **Final completion:** 2015-06
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2017-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197040, "Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01197040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*